T. Rowe Price Associates’s Zenas BioPharma, Inc. Common Stock ZBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.7M	Sell	485,202 -32,404	-6%	-$314K	﹤0.01%	1289
2025 Q1	$4.09M	Buy	517,606 +6,386	+1%	+$50.5K	﹤0.01%	1307
2024 Q4	$4.19M	Buy	511,220 +24,366	+5%	+$200K	﹤0.01%	1327
2024 Q3	$8.24M	Buy	+486,854	New	+$8.24M	﹤0.01%	1178